Xiros

Xiros is a British medical device company founded in 1982 and based in Leeds, UK. Specializing in the design, development, manufacture, and supply of implantable textile-based scaffolds, Xiros primarily serves the sports medicine and orthopedic markets. The company originated from research collaboration between Dr. Bahaa Seedhom and Dr. Kyosuke Fujikawa, leading to the creation of the Leeds-Keio Ligament, a pioneering textile-based implant for ligament reconstruction. Operating globally, Xiros launched a North American branch in 2019 to cater to the US and Canadian markets. Their product portfolio includes a variety of sterile medical devices focused on ligament, tendon, and soft tissue repair, marketed under the brand name Neoligaments. In addition to their own products, Xiros offers research, development, design, and manufacturing services to other orthopedic companies. The company is committed to innovation and sustainability, actively pursuing environmental initiatives and maintaining a strong financial position.

• Employees 55
• Founded 1982